Cite
HARVARD Citation
Putananickal, N. et al. (2022). Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial. Cephalalgia. pp. 302-311. [Online].